Product Images Irinotecan Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Irinotecan Hydrochloride NDC 72485-213 by Armas Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - 7248521315

image description - 7248521315

This is a drug called Irinotecan Hydrochloride, supplied as a sterile aqueous solution in a single-dose vial. Each mL of the solution contains 20mg of the active ingredient, Irinotecan Hydrochloride (as trihydrate) with sorbitol powder, lactic acid, and water for injection as other components. The drug is intended for intravenous use only and is labeled as a cytotoxic agent. The drug package contains important information on dosage, storage, and disposal, including the need to discard any unused portion. The drug is manufactured by Armas Pharmaceuticals in the US and distributed by Shilpa Medicare Limited in India.*

image description - Fig3

image description - Fig3

This is a Figure 3 which displays the probability of survival of patients who received second-line Irinotecan treatment compared to best supportive care (BSC) in Study 7. The data includes the number of patients (N) which was 189, the median follow-up which was 13 months, and the median survival time in months which was 92 for Irinotecan and 65 for BSC. It also indicates the use of a log-rank test.*

image description - Fig4

image description - Fig4

image description - structure

image description - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.